You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

172 Results
Guidelines and Advice
Status: Current
ID: 5-9
Version: 2
Jan 2020
Guidelines and Advice
Status: Current
ID: GL #4-4v2
Version: 2
Sep 2020
Statistical Reports
Oct 2020
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Status: In-Review
ID: GL END 7-3
Version: 4
Apr 2020
Drug
Other Name(s): Vepesid®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2020
Drug
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2020
Drug
Other Name(s): Faslodex®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2024
Drug
Other Name(s): Zinecard®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2020
Drug
Other Name(s): Procytox®
Quick Link(s): Drug Monograph, Patient Info Sheet
Oct 2020
Drug
Other Name(s): Tagrisso®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2024
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
DOCEtaxel,
cyclophosphamide,
trastuzumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph, Patient Info Sheet (CYCLDOCE)
Jan 2024

Pages